The use of diclazuril in extended withdrawal anticoccidial programs: 2. Immunity to Eimeria tenella challenge after drug withdrawal

Parasitological and histopathological examination of Cocktail love birds infected with Eimeria aratinga (Apicomplexa: Eimeriidae)

Coccidiosis is a devastating worldwide disease and is considered a dreadful disease in lovebirds. Indeed, a problem has been appeared cocktail lovebirds kept in a private pet birdhouse in Sheikh Zayed City, Giza, Egypt, in the shape of blood-tinged diarrhea, birds huddled together and showing signs of inappetence, ruffled feathers, unable to fly, general weakness and emaciation associated with high mortalities. Therefore, this study aimed to diagnose and find a suitable treatment to overcome such problems. To achieve this aim, blood and droppings samples were collected from infected and healthy birds for parasitological and hematological examinations, and tissue samples were collected from freshly dead birds for postmortem and histopathological examinations. A treatment trial was adopted on 50 infected birds and 25 healthy and parasitological negative birds and groups were classified as follows: group 1) 25 infected birds treated with Diclazuril, group 2) infected birds treated with Coccicure, and group 3) 25 birds kept as control negative reference birds. The parasitological identification revealed the presence of Eimeria aratinga (E. aratinga) oocysts in the infected bird intestine. Finally, we concluded that E. aratinga is a serious protozoon parasite infesting lovebirds revealing severe clinical signs, high mortalities, histopathological changes in the intestine and alteration in blood parameters. Diclazuril is an effective drug in treating E. aratinga in cocktail lovebirds.

Effect of butyrate, clopidol and their combination on the performance of broilers infected with Eimeria maxima

1. The effect of butyric acid glycerides (BAGs) with and without clopidol (CLP) on Eimeria maxima on growth and associated biochemical variables was investigated in broiler chickens. 2. One-day-old chicks were divided into 6 equal groups (Gps) of 30 chicks each; each group was subdivided into 6 equal subgroups. Gp 1 was not infected and not treated. Chicks in Gp 2 were not infected and fed on a ration mixed with 4 g BAGs/kg for 6 successive weeks. Chicks of the other groups were directly inoculated intra-crop with 1 × 10(4) sporulated oocysts of E. maxima at 14 d of age. Gp 3 was infected and not treated. Chicks in the remaining three groups were given diets mixed with the tested drugs for 6 successive weeks. Gp 4 was fed on a diet mixed with CLP (125 g/kg). Gp 5 was given a diet mixed with BAGs (4 g/kg diet). Gp 6 was fed on a diet mixed with both BAGs (4 g/kg diet) and CLP (125 g/kg). 3. Birds in Gps 5 and 6 showed a reduction in the mean oocyst count, lesion scores and developmental stages in the lamina propria and improved growth and biochemical variables. BAG supplementation enhanced growth and production of healthy broilers. 4. It was concluded that BAGs were a useful supplement in broiler diets as an alternative to growth promoters and antimicrobial drugs.

Control of Coccidiosis in Turkeys with Diclazuril and Monensin: Effects upon Performance and Development of Immunity toEimeriaSpecies

The effects of diclazuril and monensin, when included in the feed of turkeys from 0 to 10 wk, upon performance and development of immunity to Eimeria species was investigated. Birds were initially inoculated with a low dose of oocysts of three species of Eimeria at 3, 5, 7, and 9 days of age in order to simulate a natural infection. Weight gain and feed intake from 0 to 6 wk of age was significantly greater in medicated birds compared with those that received no anticoccidial medication. Weight gain and feed intake from 6 to 10 wk was greater in birds that received diclazuril than in unmedicated birds. No differences in performance were evident after drug withdrawal from 10 to 16 wk. Immunity to Eimeria species developed by 10 wk in birds that received no anticoccidial medication but did not develop in those given diclazuril or monensin.